Showing results (1-10 of 135) with videos related to
Sort By:
Pageof 14
Health Affairs (Project Hope)|June 2, 2025
Site-Neutral Payment And Biosimilars Competition Are Complementary Purchaser Strategies For Cancer BiologicsJames C Robinson, Christopher M WhaleyThe New England Journal of Medicine|August 17, 2017
Association of Reference Pricing with Drug Selection and SpendingJames C Robinson, Christopher M Whaley, Timothy T BrownJAMA|March 11, 2026
Hospital Adoption and Pricing for Oncology BiosimilarsJames C Robinson, Ari D Kosorukov, Christopher M WhaleyThe American Journal of Managed Care|April 11, 2024
Prices and complications in hospital-based and freestanding surgery centersJames C Robinson, Christopher M Whaley, Sanket S DhruvaHealth Affairs (Project Hope)|September 8, 2021
Price Differences To Insurers For Infused Cancer Drugs In Hospital Outpatient Departments And Physician OfficesJames C Robinson, Christopher M Whaley, Timothy T BrownHealth Affairs Scholar|May 1, 2026
Impact on hospitals of price reductions for physician-administered biologicsJames C Robinson, Mark Thomson, Ari D Kosorukov, et al.Journal of Health Economics|July 13, 2019
Provider responses to online price transparencyChristopher M WhaleyRand Health Quarterly|September 6, 2021
Prices Paid to Hospitals by Private Health Plans Are High Relative to Medicare and Vary Widely: Findings from an Employer-Led Transparency InitiativeChapin White, Christopher M WhaleyJournal of Public Economics|August 5, 2024
The Effects of Physician Vertical Integration on Referral Patterns, Patient Welfare, and Market DynamicsChristopher M Whaley, Xiaoxi ZhaoJournal of Health Economics|August 17, 2018
Firm responses to targeted consumer incentives: Evidence from reference pricing for surgical servicesChristopher M Whaley, Timothy T BrownPageof 14